Results 11 to 20 of about 26,229 (182)

Restrictive cardiomyopathy

open access: yesMedicine of Ukraine, 2017
В статье рассматриваются вопросы классификации, этиологии, патогенеза, клиники, диагностики и лечения рестриктивной кардиомиопатии (РКМП) как широкого спектра заболеваний, объединенных одним патофизиологическим механизмом рестриктивной диастолической дисфункции вследствие распространенного фиброза или инфильтрации стенок желудочков различными ...
E. A. Butko, K. Yu. Kinoshenko
exaly   +6 more sources

Restrictive Cardiomyopathy [PDF]

open access: yesNew England Journal of Medicine, 1997
S S, Kushwaha, J T, Fallon, V, Fuster
exaly   +7 more sources

Unusual case of restrictive cardiomyopathy in young

open access: yesIHJ Cardiovascular Case Reports, 2022
Restrictive cardiomyopathy (RCM) is an uncommon form of cardiomyopathy and is characterized by impaired ventricular filling due to increased myocardial stiffness.
Archit Dahiya   +4 more
doaj   +1 more source

Restrictive cardiomyopathy: definition and diagnosis. [PDF]

open access: yesEur Heart J, 2022
Rapezzi C   +8 more
europepmc   +2 more sources

NON ISCHEMIC CARDIOMYOPATHY – A CASE REPORT

open access: yesLiaquat Medical Research Journal, 2023
Cardiomyopathies are a group of diseases characterized by the structural and functional abnormalities of the heart muscles in the absence of other illnesses that might be responsible for the observed myocardial anomaly.
Anny Ashiq Ali Anny Ashiq Ali   +1 more
doaj   +1 more source

Outcomes after heart transplantation in patients with cardiac sarcoidosis

open access: yesESC Heart Failure, 2022
Background The number of patients with sarcoidosis requiring heart transplantation (HT) is increasing. The aim of this study was to evaluate outcomes of isolated HT in patients with sarcoid cardiomyopathy and compare them to recipients with non‐ischaemic
Rabea Asleh   +8 more
doaj   +1 more source

Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real‐World Data

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Cardiomyopathy is a common cause of atrial fibrillation (AF) and may also present as a complication of AF. However, there is a scarcity of evidence of clinical outcomes for people with cardiomyopathy and concomittant AF. The aim of the present
Benjamin J. R. Buckley   +5 more
doaj   +1 more source

Time spent with cats is never wasted: Lessons learned from feline acromegalic cardiomyopathy, a naturally occurring animal model of the human disease [PDF]

open access: yes, 2018
BackgroundIn humans, acromegaly due to a pituitary somatotrophic adenoma is a recognized cause of increased left ventricular (LV) mass. Acromegalic cardiomyopathy is incompletely understood, and represents a major cause of morbidity and mortality.
A Colao   +80 more
core   +2 more sources

Absence of Myocardial Thyroid Hormone Inactivating Deiodinase Results in Restrictive Cardiomyopathy in Mice [PDF]

open access: yes, 2012
Cardiac injury induces myocardial expression of the thyroid hormone inactivating type 3 deiodinase (D3), which in turn dampens local thyroid hormone signaling.
Antonio C. Bianco   +35 more
core   +1 more source

Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy [PDF]

open access: yes, 2015
Aim Dilated cardiomyopathy (DCM) has a variety of causes, and no useful approach to predict left ventricular (LV) remodelling and long-term outcome has yet been established.
Anzai, T   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy